Cite
HARVARD Citation
Minakata, D. et al. (n.d.). A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis. Leukemia research. pp. 82-87. [Online].